CU Innovations specializes in commercializing technology, developing ventures, and building business partnerships. We are the resource for biomedical technology commercialization for both the University of Colorado Anschutz Medical Campus and Denver Campus. For assistance, contact one of our team members below or complete this contact form.
(303) 724 - 0222 | email@example.com
Kimberly joined the University of Colorado in June 2015 with more than 15 years of experience in intellectual property management, licensing, research partnerships with corporations, and the formation of venture capital-financed startup companies. Kimberly was formerly the Deputy Director of the Yale Entrepreneurial Institute (YEI), and Associate Director of New Ventures at Yale University in the Office of Cooperative Research. Yale’s Office of Cooperative Research has started more than 70 new ventures that have raised $5 billion in investor capital.
Previously, Kimberly managed the intellectual property and licensing for Curagen Corporation (acquired by Celldex Therapeutics), and was co-founder of Arbor Fuel, a biofuel company that utilized recombinant microorganisms for the production of ethanol and butanol.
Kimberly began her career in New York as a patent attorney for Chadbourne and Parke, LLP and Morgan & Finnegan, LLP where her practice focused on pharmaceutical patent litigation. Kimberly has a graduate degree in genetics from the University of Connecticut and earned her Juris Doctorate with honors from the University of Connecticut School of Law. She is licensed to practice law in both New York and Connecticut.
(303) 724 - 4068 | firstname.lastname@example.org
James joined the Licensing Group of CU Innovations in January 2018. As the Manager of Pharmaceutical Development and Intellectual Property, he works closely with research scientists helping transition their creations from the laboratory to the public.
His legal practice focuses on the acquisition and development of intellectual property, including the filing and prosecution of patents, as well as the negotiation and licensing of patented inventions. He is also actively engaged with campus investigators in advising how to commercialize and develop novel medications and formulations discovered at the Anschutz Medical Campus. James has extensive experience with both healthcare and technology innovation, having worked as a pharmacist for Walgreens Co., an intellectual property attorney with Morris, Nichols, Arsht and Tunnell, LLP, and a research assistant at ImmunoTox, Inc.
James obtained his Doctor of Pharmacy and Masters of Pharmacy Administration from the University of Mississippi. He earned his Juris Doctor from William and Mary Law School. He received a Bachelor of Science in Chemistry from James Madison University. James is admitted to practice law in Delaware, Mississippi and Colorado. He is also a licensed pharmacist in Mississippi and Colorado.
(303) 724-1255 | email@example.com
(303) 724 - 0220 | firstname.lastname@example.org
(303) 724 - 1042 | email@example.com
(303) 724 - 1061 | firstname.lastname@example.org
(303) 724 - 1084 | email@example.com
(303) 724 - 1098 | firstname.lastname@example.org
Dallas Martin serves as Associate Counsel in the CU Innovations Office at the University of Colorado Anschutz Medical Campus.
(303) 724 - 0184 | email@example.com
Copy Copy Copy
(303) 724 - 1329 | firstname.lastname@example.org
(303) 724 - 4058 | email@example.com
(303) 724 - 1039 | firstname.lastname@example.org
(303) 724 - 1042 | email@example.com
(303) 724 - 9543 | firstname.lastname@example.org
(303) 724 - 4003 | email@example.com
(303) 724 - 1068 | firstname.lastname@example.org
Rolfe manages the CU Innovations brand, communications, and website.
(303) 724 - 3720 | email@example.com
Correspondence, scheduling, and directions
Tyler joined the CU Innovations team in June 2019 as a Technology Marketing Analyst. He is a Materials Chemistry PhD student at the University of Colorado Boulder campus. Tyler's research concerns semiconductor processing where he and his lab work closely with companies like Intel, Tokyo Electron, and Lam Research to develop processes for fabricating cutting-edge nanotechnology devices. Currently he is working on etching nanoparticles for applications in solar energy. Tyler has a Bachelor of Chemistry and Mathematics from Elmira College in upstate New York.
Nina is currently a student in the Biomedical Science and Biotechnology Master's program. She conducts research in the Department of Neurology focused on identifying biomarkers for neurodegenerative diseases using mosaic aneuploidy. Previously, she studied the expression and regulation of the Rap genes in breast cancer. Nina has a B.S. in Biology with a minor in Chemistry from the University of St. Thomas in Minnesota.
Melissa is currently a third year medical student at the University of Colorado Anschutz Medical Campus. She previously attended the University of Colorado Boulder where she received a BS in Chemical and Biological Engineering. She then went on to receive her PhD in Bioengineering at University of Colorado Denver. Melissa's primary research focuses on the design, synthesis, and characterization of multifunctional biomaterials for clinical applications. She has worked on a variety of research projects aimed at establishing platforms for targeted drug delivery, injectable biomaterials for tissue engineering, and nanoparticle materials for diagnostic use. Her most recent research involves the development of a new diagnostic approach for HER2-positive breast cancer.
13001 East 17th Place
Mail Stop F411
Aurora, CO 80045